The Effect of Antiretroviral Therapy on Placenta Size and Fetal Development
DOI:
https://doi.org/10.47611/jsrhs.v12i2.4292Keywords:
HIV, Antiretroviral therapy, Pregnancy, Placenta, Fetal DevelopmentAbstract
HIV, or human immunodeficiency virus, is a virus that targets the human body’s immune system and weakens it so that it struggles to defend against other pathogens designed to harm the body. In order to enhance immune health and decrease the transmission of HIV, patients who have HIV are treated with antiretroviral therapy, or ART, a treatment that seeks to reduce the replication of HIV by disrupting a specific portion of the HIV replication cycle. However, while it does reduce the vertical transmission of HIV between mother and fetus, the use of antiretroviral therapy during pregnancy can have adverse impacts on the size of the placenta and the development of the fetus. Through the study of various research papers, a distinct connection between the use of antiretroviral therapy and the placenta size and fetal development was made. Analyzing the placenta and birth characteristics of fetuses from both women with and without HIV, overall the placentas of mothers with HIV taking ART drugs had smaller diameters, weights, and areas, along with an irregular shape, than mothers without HIV; the fetuses of mothers with HIV taking ART drugs had smaller weights at birth, weeks gestation at birth, and birth weight centile than fetuses of mothers without HIV. Exploring the impacts of antiretroviral therapy on placenta size and fetal development, this comprehensive research aims to assist researchers in creating safer and improved antiretroviral drugs to treat mothers with HIV that promote both the health of the mother and the development of the child.
Downloads
References or Bibliography
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., & Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (New York, N.Y.), 220(4599), 868–871. https://doi.org/10.1126/science.6189183
Centers for Disease Control (CDC) (1982). A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR. Morbidity and mortality weekly report, 31(23), 305–307.
Centers for Disease Control and Prevention (CDC) (1996). Pneumocystis pneumonia--Los Angeles. 1981. MMWR. Morbidity and mortality weekly report, 45(34), 729–733.
Centers for Disease Control (CDC) (1982). Possible transfusion-associated acquired immune deficiency syndrome (AIDS) - California. MMWR. Morbidity and mortality weekly report, 31(48), 652–654.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., Makhema, J., … HPTN 052 Study Team (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine, 365(6), 493–505. https://doi.org/10.1056/NEJMoa1105243
De Cock, K. M., Jaffe, H. W., & Curran, J. W. (2021). Reflections on 40 Years of AIDS. Emerging infectious diseases, 27(6), 1553–1560. https://doi.org/10.3201/eid2706.210284
Eisinger, R. W., & Fauci, A. S. (2018). Ending the HIV/AIDS Pandemic1. Emerging infectious diseases, 24(3), 413–416. https://doi.org/10.3201/eid2403.171797
Greene W. C. (2007). A history of AIDS: looking back to see ahead. European journal of immunology, 37 Suppl 1, S94–S102. https://doi.org/10.1002/eji.200737441
Fanales-Belasio, E., Raimondo, M., Suligoi, B., & Buttò, S. (2010). HIV virology and pathogenetic mechanisms of infection: a brief overview. Annali dell'Istituto superiore di sanita, 46(1), 5–14. https://doi.org/10.4415/ANN_10_01_02
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., Tatem, A. J., Sousa, J. D., Arinaminpathy, N., Pépin, J., Posada, D., Peeters, M., Pybus, O. G., & Lemey, P. (2014). HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations. Science (New York, N.Y.), 346(6205), 56–61. https://doi.org/10.1126/science.1256739
Fowler, M. G., Qin, M., Fiscus, S. A., Currier, J. S., Flynn, P. M., Chipato, T., McIntyre, J., Gnanashanmugam, D., Siberry, G. K., Coletti, A. S., Taha, T. E., Klingman, K. L., Martinson, F. E., Owor, M., Violari, A., Moodley, D., Theron, G. B., Bhosale, R., Bobat, R., Chi, B. H., … IMPAACT 1077BF/1077FF PROMISE Study Team (2016). Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. The New England journal of medicine, 375(18), 1726–1737. https://doi.org/10.1056/NEJMoa1511691
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., Leibowitch, J., & Popovic, M. (1983). Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science (New York, N.Y.), 220(4599), 865–867. https://doi.org/10.1126/science.6601823
Justiz Vaillant, A. A., & Gulick, P. G. (2022). HIV Disease Current Practice. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK534860/#_NBK534860_pubdet_
Pau, A. K., & George, J. M. (2014). Antiretroviral therapy: current drugs. Infectious disease clinics of North America, 28(3), 371–402. https://doi.org/10.1016/j.idc.2014.06.001
Pebody, R. (2021). Types of antiretroviral medications. Aidsmap. Retrieved from https://www.aidsmap.com/about-hiv/types-antiretroviral-medications
Salafia, C. M., Maas, E., Thorp, J. M., Eucker, B., Pezzullo, J. C., & Savitz, D. A. (2005). Measures of placental growth in relation to birth weight and gestational age. American journal of epidemiology, 162(10), 991–998. https://doi.org/10.1093/aje/kwi305
Salafia, C. M., Yampolsky, M., Misra, D. P., Shlakhter, O., Haas, D., Eucker, B., & Thorp, J. (2010). Placental surface shape, function, and effects of maternal and fetal vascular pathology. Placenta, 31(11), 958–962. https://doi.org/10.1016/j.placenta.2010.09.005
Salafia, C. M., Zhang, J., Miller, R. K., Charles, A. K., Shrout, P., & Sun, W. (2007). Placental growth patterns affect birth weight for given placental weight. Birth defects research. Part A, Clinical and molecular teratology, 79(4), 281–288. https://doi.org/10.1002/bdra.20345
Yampolsky, M., Shlakhter, O., Deng, D., Kala, S., Walmsley, S. L., Murphy, K. E., Yudin, M. H., MacGillivray, J., Loutfy, M., Dunk, C., & Serghides, L. (2021). Exploring the impact of HIV infection and antiretroviral therapy on placenta morphology. Placenta, 104, 102–109. https://doi.org/10.1016/j.placenta.2020.12.004
Zash, R., Jacobson, D. L., Diseko, M., Mayondi, G., Mmalane, M., Essex, M., Petlo, C., Lockman, S., Makhema, J., & Shapiro, R. L. (2017). Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy. JAMA pediatrics, 171(10), e172222. https://doi.org/10.1001/jamapediatrics.2017.22
Published
How to Cite
Issue
Section
Copyright (c) 2023 Anjali Nambakam
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
